Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin crossover study on postprandial blood pressure variability in type 2 diabetes
ACTRN12619001060134Phase 4Completed
- Sponsor
- Royal Adelaide Hospital
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Royal Adelaide Hospital. Primary endpoint: Maximum fall in systolic blood pressure. Started Dec 2019; status: completed.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ACTRN12619001060134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619001060134.